ClinicalTrials.gg
RecruitingNCT06991400TTTS TAPSUpdated May 28, 2025

Evaluation of Laparotomy With Trans-Amniotic Suture Placement in TTTS Surgery

An interventional study of Trans-Amniotic Suture Placement in Twin to Twin Transfusion Syndrome and Twin Anemia-Polycythemia Sequence, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This is a randomized trial for patients that are diagnosed with Twin-Twin Transfusion Syndrome (TTTS) who are receiving a fetoscopic laser surgery to evaluate the effectiveness and safety of a laparotomy closure.

Read the detailed description

The rationale behind suturing the hole is that the amniotic membrane does not close itself, rather you are relying that the uterus closes over the hole in the amniotic membrane, which may or may not happen, as well as in fetoscopic surgery for another condition, myelomeningocele. Published data has shown that maternal laparotomy to suture closure of the port site at the time of fetoscopic surgery leads to improved pregnancy outcomes, later gestational age at delivery, and lower rates of preterm pre-labor rupture of membranes (PPROM) [PMID: 28910784].

02

Conditions studied

  • Twin to Twin Transfusion Syndrome
  • Twin Anemia-Polycythemia Sequence

Browse trials for

Keywords

  • fetoscopic surgery, laparotomy
03

In context

Fetofetal Transfusion

31 studies on the registry are indexed under Fetofetal Transfusion; 13 are open to participants now.

This study's planned enrollment of 34 is below the median of 160 across 17 interventional studies indexed under Fetofetal Transfusion.

Browse Fetofetal Transfusion studies →

Lead sponsor

Children's Hospital Medical Center, Cincinnati is the lead sponsor of 673 studies on the registry; 134 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 31 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of TTTS or Twin Anemia-Polycythemia Sequence (TAPS)
  • Gestational age between 18 weeks and 23 weeks (18 0/7 to 22 6/7 weeks)
  • Cervical length >2.5 cm preoperatively
  • Identification of a safe percutaneous surgical window by a provider experienced in fetoscopic surgery prior to entering the operating room

Exclusion criteria

Exclusion Criteria:

  • Higher order pregnancies, chromosomal or severe congenital anomalies, undergoing laser surgery for fetal growth restriction only, need for a second laser during pregnancy, failure to complete laser, PPROM prior to surgery. BMI> 40 at the start of pregnancy, emergent case (i.e. surgery occurs \< 6 hours from presentation), significant fetal anomalies expected to drastically alter the risk of neonatal morbidity or mortality (i.e. anencephaly, cyanotic heart disease), or any significant maternal comorbidities as determined by physician i.e.: clotting disorders/blood disorders.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    yes stitch (will receive a larger stitch from laparotomy)

    yes stitch for a larger stitch when receiving a laparotomy.

    Other: Trans-Amniotic Suture Placement

  • No intervention
    No stitch

Interventions

  • OtherTrans-Amniotic Suture Placement

    Trans-Amniotic Suture placement

06

What researchers measure

Primary outcomes

  1. Latency from surgery to delivery

    Will a transuterine suture placement cause later gestational age at delivery in babies with TTTs.

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
  • Cincinnati Childrens Hospital Medical Center
    Cincinnati, Ohio 45229, United States
    • Braxton Forde · Sub investigator
    Recruiting
08

References and documents

Publications

  • Forde B, Sepulveda Gonzalez G, Lim FY, Arroyo-Lemarroy T, Nava Geurrero EN, Lizarraga-Cepeda E, Habli M, McKinney D, Hoffman M, Peiro JL. Should We Stitch-Close the Fetoscopic Percutaneous Access? A Case-Series of Laparotomy to Trans-Amniotic Membrane Suturing for Intrauterine Port Placement in Fetoscopic Surgery for Twins. Fetal Diagn Ther. 2024;51(5):510-515. doi: 10.1159/000539894. Epub 2024 Jun 18. PubMed 38889699 ↗
  • Kabagambe SK, Jensen GW, Chen YJ, Vanover MA, Farmer DL. Fetal Surgery for Myelomeningocele: A Systematic Review and Meta-Analysis of Outcomes in Fetoscopic versus Open Repair. Fetal Diagn Ther. 2018;43(3):161-174. doi: 10.1159/000479505. Epub 2017 Sep 15. PubMed 28910784 ↗

Individual participant data

Plan to share: No — We are using the data for CCHMC only.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06991400
Responsible party
Foong-Yen Lim (Surgical Director, Children's Hospital Medical Center, Cincinnati) — Principal investigator
First posted
May 28, 2025
Start date
Nov 1, 2024
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
May 28, 2025

Study contacts

Kimberly Richards
Contact
kimberly.richards@cchmc.org
513-636-2310
Erin Watters
Contact
erin.watters@cchmc.org
513-803-7024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion